ARTV Artiva Bio drops 867 after Q4 2025 EPS posts narrow miss versus analyst estimates Strait of Hormuz Disruption Asian Supply Shock Spillover Risks for the US Economy Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval Is Turn Therapeutics TTRX stock changing direction Aon plc AON Q1 2026 Earnings Preview Core Segment Growth Faces Off Against Wealth Solutions Headwinds DGII Digi posts narrow Q1 2026 EPS beat shares dip 024 percent on muted investor sentiment Vanguard Financials Index Fund ETF VFH Poised for Upside Amid Big Bank Q1 Earnings Catalysts and Steepening Yield Curve Tailwinds RDI Reading International Q3 2025 EPS lands far below forecasts shares drop 265 on weak quarterly results Bank First BFC Breakout Watch Bank First logs 195 EPS miss vs street estimates US Government and Frontier AI Firm Collaboration Talks Amid Ongoing Procurement Litigation RERE ATRenew reports Q4 2025 EPS 335 percent below estimates as its shares climb 25 percent